Quest Diagnostics Earnings
NYSE: DGXHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 22, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$2.85
Quest Diagnostics earnings summary
Quest Diagnostics is scheduled to report Sep/2026 earnings on Oct 22, 2026 before the market opens, with analysts expecting EPS of $2.85. In its most recent report on Jul 23, 2026 (Q2 2026), DGX posted EPS of $2.84. Revenue for the quarter was $3.04 billion.
Quarterly EPS is up 15.0% from the same quarter a year earlier. Across the last 16 reports, DGX shares moved an average of 2.4% (in either direction) in the first trading session after results, rising 11 times and falling 5 times.
Summary generated from market data by MetaCap's automated system. Methodology
DGX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 23, 2026 | — | $2.84 | — | +2.3% |
| Apr 22, 2026 | — | $2.24 | — | -1.8% |
| Feb 26, 2026 | — | $2.18 | — | -6.0% |
| Oct 21, 2025 | — | $2.16 | — | -3.4% |
| Jul 23, 2025 | — | $2.47 | — | +1.4% |
| Apr 23, 2025 | — | $1.94 | — | +2.4% |
| Feb 20, 2025 | — | $1.95 | — | +0.4% |
| Oct 23, 2024 | — | $1.99 | — | +0.2% |
| Jul 24, 2024 | — | $2.03 | — | +3.1% |
| Apr 24, 2024 | — | $1.72 | — | +2.3% |
| Feb 22, 2024 | — | $1.70 | — | -1.9% |
| Oct 25, 2023 | — | $1.96 | — | +4.9% |
| Jul 27, 2023 | — | $2.05 | — | +0.9% |
| Apr 28, 2023 | — | $1.78 | — | -1.7% |
| Feb 21, 2023 | — | $0.92 | — | +0.6% |
| Oct 21, 2022 | — | $2.17 | — | +5.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.